Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

605 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial.
Prado GFA Jr, Abizaid AAC, Meireles GC, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado AD, Jr JM, Perin MA, Costantini C, Costa R, Costa JR, Chamie D, Campos CM, Ribeiro EE, Lemos PA. Prado GFA Jr, et al. Among authors: costa jr, jr jm, costa r. Rev Port Cardiol (Engl Ed). 2021 Feb;40(2):71-76. doi: 10.1016/j.repc.2020.05.017. Epub 2021 Jan 2. Rev Port Cardiol (Engl Ed). 2021. PMID: 33402278 Free article. Clinical Trial. English, Portuguese.
Very late thrombosis after drug-eluting stents.
Feres F, Costa JR Jr, Abizaid A. Feres F, et al. Among authors: costa jr jr. Catheter Cardiovasc Interv. 2006 Jul;68(1):83-8. doi: 10.1002/ccd.20692. Catheter Cardiovasc Interv. 2006. PMID: 16763989 Review.
Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry.
Sousa A, Costa JR Jr, Moreira AC, Cano M, Maldonado G, Costa RA, Pavanello R, Romano ER, Campos C, Haddad N, Abizaid A, Feres F, Mattos LA, Staico R, Sousa JE; Drug-Eluting Stents in the Real World (DESIRE) Registry. Sousa A, et al. Among authors: costa jr jr, costa ra. J Interv Cardiol. 2008 Aug;21(4):307-14. doi: 10.1111/j.1540-8183.2008.00379.x. J Interv Cardiol. 2008. PMID: 18754966 Free article.
Correlation between quantitative angiographic and intravascular ultrasound parameters in patients treated with sirolimus analogous-eluting stents.
Lasave LI, Costa JR Jr, Costa R, Abizaid A, Feres F, Staico R, Maldonado G, Mattos LA, Beraldo P, Sousa AG, Sousa JE, Abizaid A. Lasave LI, et al. Among authors: costa jr jr, costa r. Int J Cardiovasc Imaging. 2009 Apr;25(4):345-51. doi: 10.1007/s10554-009-9431-8. Epub 2009 Jan 31. Int J Cardiovasc Imaging. 2009. PMID: 19184633
Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
Costa JR Jr, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, Mattos LA, Staico R, Siqueira D, Sousa AG, Bonan R, Sousa JE. Costa JR Jr, et al. Among authors: costa r. JACC Cardiovasc Interv. 2008 Oct;1(5):545-51. doi: 10.1016/j.jcin.2008.07.003. JACC Cardiovasc Interv. 2008. PMID: 19463357 Free article.
1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial.
Costa JR Jr, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, Maldonado G, Staico R, Siqueira D, Sousa AG, Bonan R, Sousa JE. Costa JR Jr, et al. Among authors: costa r. JACC Cardiovasc Interv. 2009 May;2(5):422-7. doi: 10.1016/j.jcin.2009.02.009. JACC Cardiovasc Interv. 2009. PMID: 19463465 Free article.
605 results